Rheumatoid Arthritis Biologics Increase Risk of Common Skin Cancer, University of Manchester Study  
10/19/2009 7:23:17 AM

Bookmark and Share

MedPage Today -- PHILADELPHIA -- Rheumatoid arthritis patients treated with potent tumor necrosis factor inhibitors run an increased risk of developing skin cancer, researchers said here at the American College of Rheumatology's annual meeting.